BNP PARIBAS ARBITRAGE, SA
Position in CATX — Perspective Therapeutics, Inc.
CIK 1166588
NEW YORK, NY
Position in CATX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$90,326
+$55,924 QoQ
Shares Held
21,661
+73.1% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $1,711,271,467 across 97 Medical Devices names. CATX ranks #64 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
3,712,243 | $381,135,988 | |
| 2 | BSX |
Boston Scientific Corp
|
5,101,806 | $320,138,326 | |
| 3 | SYK |
Stryker Corp
|
741,255 | $243,568,980 | |
| 4 | MDT |
Medtronic plc
|
2,518,123 | $218,195,357 | |
| 5 | DXCM |
Dexcom Inc
|
1,600,989 | $100,542,109 | |
| 6 | EW |
Edwards Lifesciences Corp
|
922,938 | $73,908,875 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
932,136 | $66,349,440 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
407,068 | $36,807,088 |
All Filings in CATX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $90,326 | 21,661 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $34,402 | 12,510 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $355,814 | 103,736 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $834,578 | 242,610 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $157,965 | 74,162 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $162,989 | 51,094 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $634,992 | 47,565 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $33,808 | 3,391 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||